Chronic lipopolysaccharide exposure induces cognitive dysfunction without affecting BDNF expression in the rat hippocampus

Zhu,Bin; Wang,Zhi‑Gang; Ding,Jie; Liu,Ning; Wang,Da‑Ming; Ding,Liang‑Cai; Yang,Chun

doi:10.3892/etm.2014.1479

Chronic lipopolysaccharide exposure induces cognitive dysfunction without affecting BDNF expression in the rat hippocampus

Authors:
- Bin Zhu
- Zhi‑Gang Wang
- Jie Ding
- Ning Liu
- Da‑Ming Wang
- Liang‑Cai Ding
- Chun Yang
View Affiliations

Affiliations: Department of Critical Care Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu 213003, P.R. China, Department of Respiratory Medicine, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu 213003, P.R. China, Department of Anesthesiology, The Third Affiliated Hospital of Soochow University, Changzhou, Jiangsu 213003, P.R. China
Published online on: January 8, 2014 https://doi.org/10.3892/etm.2014.1479
Pages: 750-754

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Previous studies have shown that lipopolysaccharide (LPS) has the potential to cause cognitive dysfunction. However, the underlying pathogenesis has yet to be fully elucidated. Increasing attention is being focused on infection in the central nervous system. Therefore, the present study aimed to investigate the behavioral performance of rats receiving intraperitoneal injections of LPS and to determine the expression levels of amyloid‑β (Aβ), brain‑derived neurotrophic factor (BDNF) and pro‑inflammatory cytokines in the hippocampus. In total, 30 male Wistar rats were randomly divided into 3 groups (each n=10): Control and 3 and 7 day LPS administration groups. The rats were intraperitoneally injected with saline or LPS for 3 or 7 days. Following this, rats performed the Morris water maze test, in which the latency to the platform and proportion of time spent in the target quadrant were recorded. Rats were then sacrificed and the hippocampi were harvested for determination of interleukin (IL)‑1β, IL‑6, tumor necrosis factor‑α (TNF‑α), Aβ and BDNF expression levels. LPS administration for 3 and 7 days significantly increased the latency to the platform and decreased the proportion of time spent in the target quadrant compared with those in the control group, (P<0.05). Administration of LPS for 3 and 7 days induced statistically significant increases in the expression levels of IL‑1β, IL‑6 and TNF‑α in the hippocampus, compared with those in the control group (P<0.05). Additionally, the administration of LPS for 7 days induced a statistically significant increase in the expression level of Aβ in the hippocampus, compared with that in the control group (P<0.05). However, the administration of LPS did not elicit a statistically significant change in the expression level of BDNF in the hippocampus, compared with that in the control group (P>0.05). The results indicate that LPS induces cognitive dysfunction, which is associated with increased expression levels of pro‑inflammatory cytokines and Aβ, but does not affect the expression of BDNF in the hippocampus.

View Figures

View References

1	Adam N, Kandelman S, Mantz J, Chrétien F and Sharshar T: Sepsis-induced brain dysfunction. Expert Rev Anti Infect Ther. 11:211–221. 2013. View Article : Google Scholar
2	Zampieri FG, Park M, Machado FS and Azevedo LC: Sepsis-associated encephalopathy: not just delirium. Clinics (Sao Paulo). 66:1825–1831. 2011. View Article : Google Scholar : PubMed/NCBI
3	Guan Z and Fang J: Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats. Brain Behav Immun. 20:64–71. 2006. View Article : Google Scholar : PubMed/NCBI
4	Suzumura A, Takeuchi H, Zhang G, Kuno R and Mizuno T: Roles of glia-derived cytokines on neuronal degeneration and regeneration. Ann NY Acad Sci. 1088:219–229. 2006. View Article : Google Scholar : PubMed/NCBI
5	Wang Y, Cui XL, Liu YF, et al: LPS inhibits the effects of fluoxetine on depression-like behavior and hippocampal neurogenesis in rats. Prog Neuropsychopharmacol Biol Psychiatry. 35:1831–1835. 2011. View Article : Google Scholar : PubMed/NCBI
6	Deng XH, Ai WM, Lei DL, Luo XG, Yan XX and Li Z: Lipopolysaccharide induces paired immunoglobulin-like receptor B (PirB) expression, synaptic alteration, and learning-memory deficit in rats. Neuroscience. 209:161–170. 2012. View Article : Google Scholar : PubMed/NCBI
7	Richwine AF, Sparkman NL, Dilger RN, Buchanan JB and Johnson RW: Cognitive deficits in interleukin-10-deficient mice after peripheral injection of lipopolysaccharide. Brain Behav Immun. 23:794–802. 2009. View Article : Google Scholar : PubMed/NCBI
8	Sparkman NL, Buchanan JB, Heyen JR, Chen J, Beverly JL and Johnson RW: Interleukin-6 facilitates lipopolysaccharide-induced disruption in working memory and expression of other proinflammatory cytokines in hippocampal neuronal cell layers. J Neurosci. 26:10709–10716. 2006. View Article : Google Scholar
9	Dantzer R, O’Connor JC, Freund GG, Johnson RW and Kelley KW: From inflammation to sickness and depression: when the immune system subjugates the brain. Nat Rev Neurosci. 9:46–56. 2008. View Article : Google Scholar : PubMed/NCBI
10	Smith CJ, Emsley HC, Udeh CT, et al: Interleukin-1 receptor antagonist reverses stroke-associated peripheral immune suppression. Cytokine. 58:384–389. 2012. View Article : Google Scholar : PubMed/NCBI
11	Krzyszton CP, Sparkman NL, Grant RW, et al: Exacerbated fatigue and motor deficits in interleukin-10-deficient mice after peripheral immune stimulation. Am J Physiol Regul Integr Comp Physiol. 295:R1109–R1114. 2008. View Article : Google Scholar : PubMed/NCBI
12	Johnston H, Boutin H and Allan SM: Assessing the contribution of inflammation in models of Alzheimer’s disease. Biochem Soc Trans. 39:886–890. 2011.PubMed/NCBI
13	Kaster MP, Gadotti VM, Calixto JB, Santos AR and Rodrigues AL: Depressive-like behavior induced by tumor necrosis factor-α in mice. Neuropharmacology. 62:419–426. 2012.
14	Mansur RB, Zugman A, Asevedo EM, da Cunha GR, Bressan RA and Brietzke E: Cytokines in schizophrenia: possible role of anti-inflammatory medications in clinical and preclinical stages. Psychiatry Clin Neurosci. 66:247–260. 2012. View Article : Google Scholar : PubMed/NCBI
15	Pizza V, Agresta A, D’Acunto CW, Festa M and Capasso A: Neuroinflamm-aging and neurodegenerative diseases: an overview. CNS Neurol Disord Drug Targets. 10:621–634. 2011. View Article : Google Scholar : PubMed/NCBI
16	Magaki S, Mueller C, Dickson C and Kirsch W: Increased production of inflammatory cytokines in mild cognitive impairment. Exp Gerontol. 42:233–240. 2007. View Article : Google Scholar : PubMed/NCBI
17	Oral E, Canpolat S, Yildirim S, Gulec M, Aliyev E and Aydin N: Cognitive functions and serum levels of brain-derived neurotrophic factor in patients with major depressive disorder. Brain Res Bull. 88:454–459. 2012. View Article : Google Scholar : PubMed/NCBI
18	Zhang XY, Liang J, Chen da C, et al: Low BDNF is associated with cognitive impairment in chronic patients with schizophrenia. Psychopharmacology (Berl). 222:277–284. 2012. View Article : Google Scholar : PubMed/NCBI
19	D’Hooge R and De Deyn PP: Applications of the Morris water maze in the study of learning and memory. Brain Res Brain Res Rev. 36:60–90. 2001.PubMed/NCBI
20	Solov’eva T, Davydova V, Krasikova I and Yermak I: Marine compounds with therapeutic potential in gram-negative sepsis. Mar Drugs. 11:2216–2229. 2013.PubMed/NCBI
21	Skelly DT, Hennessy E, Dansereau MA and Cunningham C: A systematic analysis of the peripheral and CNS effects of systemic LPS, IL-1β, TNF-α and IL-6 challenges in C57BL/6 mice. PLoS One. 8:e691232013.PubMed/NCBI
22	Shaw KN, Commins S and O’Mara SM: Lipopolysaccharide causes deficits in spatial learning in the watermaze but not in BDNF expression in the rat dentate gyrus. Behav Brain Res. 124:47–54. 2001. View Article : Google Scholar : PubMed/NCBI
23	Leung R, Proitsi P, Simmons A, et al: Inflammatory proteins in plasma are associated with severity of Alzheimer’s disease. PLoS One. 8:e649712013.
24	Reale M, Iarlori C, Gambi F, et al: Treatment with an acetylcholinesterase inhibitor in Alzheimer patients modulates the expression and production of the pro-inflammatory and anti-inflammatory cytokines. J Neuroimmunol. 148:162–171. 2004. View Article : Google Scholar
25	Hsu LJ, Mallory M, Xia Y, et al: Expression pattern of synucleins (non-Abeta component of Alzheimer’s disease amyloid precursor protein/alpha-synuclein) during murine brain development. J Neurochem. 71:338–344. 1998.
26	Nguyen JT, Yamani A and Kiso Y: Views on amyloid hypothesis and secretase inhibitors for treating Alzheimer’s disease: progress and problems. Curr Pharm Des. 12:4295–4312. 2006.PubMed/NCBI
27	Yan Q, Rosenfeld RD, Matheson CR, et al: Expression of brain-derived neurotrophic factor protein in the adult rat central nervous system. Neuroscience. 78:431–448. 1997. View Article : Google Scholar : PubMed/NCBI
28	Lapchak PA, Araujo DM and Hefti F: Systemic interleukin-1 beta decreases brain-derived neurotrophic factor messenger RNA expression in the rat hippocampal formation. Neuroscience. 53:297–301. 1993. View Article : Google Scholar
29	Maher FO, Martin DS and Lynch MA: Increased IL-1beta in cortex of aged rats is accompanied by downregulation of ERK and PI-3 kinase. Neurobiol Aging. 25:795–806. 2004. View Article : Google Scholar : PubMed/NCBI
30	Taishi P, Churchill L, De A, Obal F Jr and Krueger JM: Cytokine mRNA induction by interleukin-1beta or tumor necrosis factor alpha in vitro and in vivo. Brain Res. 1226:89–98. 2008. View Article : Google Scholar : PubMed/NCBI
31	Schnydrig S, Korner L, Landweer S, et al: Peripheral lipopolysaccharide administration transiently affects expression of brain-derived neurotrophic factor, corticotropin and proopiomelanocortin in mouse brain. Neurosci Lett. 429:69–73. 2007. View Article : Google Scholar